US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

261.30

-4.7000-1.77%

Pre-market: 264.002.70+1.03%05:46 EDT

Volume:227.38K

Turnover:60.97M

Market Cap:515.93M

PE:- -

High:278.96

Open:273.29

Low:261.30

Close:266.00

52wk High:341.93

52wk Low:74.95

Shares:1.97M

Float Shares:1.97M

Volume Ratio:0.94

T/O Rate:11.52%

Dividend:1.02

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cooper Co (COO) and Arcus Biosciences (RCUS)

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

Bayer granted accelerated approval for Hyrnuo by FDA

Bamboos Health Care Sets September Board Meeting for Annual Results and Dividend Consideration

Health Care Roundup: Market Talk

XRP Healthcare Goes Offline After Top Ex-Ripple Engineers Call Out 'Red Flags'

Table: CHC Healthcare Group Aug Rev Nt$327.6m vs Nt$283.8m

Seikagaku Faces FDA Setback on SI-6603 but No New Trials Required

Ascelia Pharma Holds FDA Type A Meeting on Orviglance NDA

Private Equity Firm TPG Explores Sale of Healthcare Software Company Lyric, Potential Valuation at $5 Billion

Top Executive Makes Bold Move With Major Healthcare Realty Trust Stock Sale

Ramsay Health Care (RMSYF) Gets a Hold from Citi

Citi Remains a Hold on Sonic Healthcare Limited (SHL)

EBOS Group Limited (EBO) Gets a Buy from Citi

Positive Report for Fisher & Paykel Healthcare Corporation Limited (FSPKF) from Citi

Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup

Health Care Roundup: Market Talk

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference

COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating

Bayer Gets FDA Accelerated Approval for Lung Cancer Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/LABU/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":261.3,"timestamp":1789156800000,"preClose":266,"halted":0,"volume":227375,"hourTrading":{"tag":"盘前","latestPrice":264,"preClose":261.3,"latestTime":"05:46 EDT","volume":444,"amount":116933.60712000002,"timestamp":1789379187090,"change":2.7,"changeRate":0.010333,"amplitude":0.011251},"delay":0,"changeRate":-0.017669172932330786,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Pre-Mkt","change":-4.7,"latestTime":"09-14 06:08:14 EDT","open":273.29,"high":278.9613,"low":261.3,"amount":60970299.293749996,"amplitude":0.066396,"askPrice":268,"askSize":19,"bidPrice":260.4,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":261.3,"sharesOutstanding":3074486,"nav":261.603,"aum":516531253.77,"dividendRate":0.0039,"bidAskSpread":0.003144,"preHourTrading":{"tag":"盘前","latestPrice":264,"preClose":261.3,"latestTime":"05:46 EDT","volume":444,"amount":116933.60712000002,"timestamp":1789379187090,"change":2.7,"changeRate":0.010333,"amplitude":0.011251},"postHourTrading":{"tag":"盘后","latestPrice":261.3,"preClose":261.3,"latestTime":"19:58 EDT","volume":728,"amount":191085.6107,"timestamp":1789171090575,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9397711565267511,"impliedVol":0.8728,"impliedVolPercentile":0.324},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9397711565267511,"shares":1974486,"dividePrice":1.0191,"high":278.9613,"amplitude":0.066396,"preClose":266,"low":261.3,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":261.3,"committee":0.826484,"eps":0,"divideRate":0.0039,"volume":227375,"delay":0,"ttmEps":0,"open":273.29,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":305.86,"twentyDayClose":273.91,"sixtyDayClose":184.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666199562","title":"Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Cooper Co (COO) and Arcus Biosciences (RCUS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666199562","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666199562?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:10","pubTimestamp":1789035029,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Brainsway (BWAY), Cooper Co (COO) and Arcus Biosci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brainsway-bway-cooper-co-coo-and-arcus-biosciences-rcus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-brainsway-bway-cooper-co-coo-and-arcus-biosciences-rcus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2211815571.USD","BK4137","XBI","LU0128526141.USD","RCUS","BK4139","BK4585","HCSG","LU1992135399.USD","BK4198","LU0029874061.USD","GB00BDT5M118.USD","XLV","BK4082","LU1992135472.HKD","BK4588","COO","LU2272731600.USD","LU2272731782.SGD","BK4581","LABU","BWAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666856274","title":"Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2666856274","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666856274?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:02","pubTimestamp":1789034520,"startTime":"0","endTime":"0","summary":"FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359280/0/en/man-group-plc-form-8-3-spire-healthcare-group-plc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","HCSG","BK4137","BK4588","XLV","LU0029874061.USD","BK4585","BK4581","LU0128526141.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666561757","title":"Bayer granted accelerated approval for Hyrnuo by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2666561757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666561757?lang=en_us&edition=fundamental","pubTime":"2026-09-10 17:30","pubTimestamp":1789032610,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that following Priority Review and Breakthrough Therapy Designation, the FDA has granted accelerated approval for Hyrnuo, f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-granted-accelerated-approval-for-hyrnuo-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-granted-accelerated-approval-for-hyrnuo-by-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","BAYRY","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666566200","title":"Bamboos Health Care Sets September Board Meeting for Annual Results and Dividend Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2666566200","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666566200?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:38","pubTimestamp":1789029500,"startTime":"0","endTime":"0","summary":"Bamboos Health Care Holdings Ltd ( ($HK:2293) ) has provided an update. Bamboos Health Care Holdings Ltd has scheduled a board meeting for 23 Septe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-sets-september-board-meeting-for-annual-results-and-dividend-consideration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bamboos-health-care-sets-september-board-meeting-for-annual-results-and-dividend-consideration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","XLV","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666566559","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666566559","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666566559?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:20","pubTimestamp":1789028400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0608 GMT - CSPC Pharmaceutical's coming clinical data presentati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XLV","XBI","BK4581","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666525558","title":"XRP Healthcare Goes Offline After Top Ex-Ripple Engineers Call Out 'Red Flags'","url":"https://stock-news.laohu8.com/highlight/detail?id=2666525558","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666525558?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:15","pubTimestamp":1789028100,"startTime":"0","endTime":"0","summary":"XRP Healthcare has officially announced the cessation of its operations and the start of a coordinated delisting of its XRPH and XRPHAI tokens. The management of the startup, which spent three years t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/xrp-healthcare-goes-offline-after-top-ex-ripple-engineers-call-out-red-flags","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/xrp-healthcare-goes-offline-after-top-ex-ripple-engineers-call-out-red-flags","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["XRPT","TOXR","XRP","XRPZ","XRPI","BITW","BK4588","XRPR","UXRP","BK4137","HCSG","LU0128526141.USD","XBI","BK4581","BK4585","XRPC","XXRP","LU0029874061.USD","LABU","XRPK","XRP.USD.CC","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666632495","title":"Table: CHC Healthcare Group Aug Rev Nt$327.6m vs Nt$283.8m","url":"https://stock-news.laohu8.com/highlight/detail?id=2666632495","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666632495?lang=en_us&edition=fundamental","pubTime":"2026-09-10 15:35","pubTimestamp":1789025700,"startTime":"0","endTime":"0","summary":"Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4581","XBI","LU0029874061.USD","XLV","BK4585","BK4588","LU0128526141.USD","BK4137","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666057563","title":"Seikagaku Faces FDA Setback on SI-6603 but No New Trials Required","url":"https://stock-news.laohu8.com/highlight/detail?id=2666057563","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666057563?lang=en_us&edition=fundamental","pubTime":"2026-09-10 15:23","pubTimestamp":1789025015,"startTime":"0","endTime":"0","summary":"The latest update is out from Seikagaku ( ($JP:4548) ). Seikagaku has received a complete response letter from the U.S. FDA regarding its biologics...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/seikagaku-faces-fda-setback-on-si-6603-but-no-new-trials-required?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/seikagaku-faces-fda-setback-on-si-6603-but-no-new-trials-required?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666955046","title":"Ascelia Pharma Holds FDA Type A Meeting on Orviglance NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2666955046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666955046?lang=en_us&edition=fundamental","pubTime":"2026-09-10 14:03","pubTimestamp":1789020181,"startTime":"0","endTime":"0","summary":"Ascelia Pharma AB ( ($SE:ACE) ) has issued an update. Ascelia Pharma has completed a Type A meeting with the U.S. Food and Drug Administration to d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ascelia-pharma-holds-fda-type-a-meeting-on-orviglance-nda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ascelia-pharma-holds-fda-type-a-meeting-on-orviglance-nda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4220","FDNI","LU0289960550.SGD","LU1770036033.HKD","SG9999002604.SGD","LU2152927971.USD","LU0048573645.USD","BK4551","LU2125910849.SGD","SG9999002414.USD","LU2543165471.USD","IE0031814969.USD","LABU","LU2065171311.SGD","SG9999005177.SGD","LU0499858602.USD","LU0823038988.USD","BK4503","LU0516422952.EUR","LU0345775950.USD","LU0516423174.USD","BK4548","LU0264606111.USD","LU0516422366.SGD","LU2125910500.SGD","LU0261945553.USD","SG9999013478.USD","BK4085","LU1861220207.SGD","SGXZ58947870.SGD","LU0251143029.SGD","LU0499858438.USD","LU0072462343.USD","BK4581","IE00BD6J9T35.USD","LU0532188223.SGD","IE0034224299.USD","LU1242518857.USD","LU0516423091.SGD","LU0572940350.SGD","IE0001KFT4U8.USD","SG9999001135.SGD","LU2360107671.USD","LU0589944569.HKD","SE","BK4554","SG9999013460.SGD","LU1861217088.USD","BK4588","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124904281","title":"Private Equity Firm TPG Explores Sale of Healthcare Software Company Lyric, Potential Valuation at $5 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1124904281","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124904281?lang=en_us&edition=fundamental","pubTime":"2026-09-10 10:54","pubTimestamp":1789008858,"startTime":"0","endTime":"0","summary":"Private equity firm TPG is reportedly exploring the sale of Lyric, a healthcare software company, according to sources familiar with the matter. The company generates approximately $250 million in...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGVV","PRVT","NOBL","VHT","IGM","LABU","XBI","PSP","BK4550","AAUM","BK4585","BK4588","BK4581","BUYO","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666551904","title":"Top Executive Makes Bold Move With Major Healthcare Realty Trust Stock Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2666551904","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666551904?lang=en_us&edition=fundamental","pubTime":"2026-09-10 10:07","pubTimestamp":1789006073,"startTime":"0","endTime":"0","summary":"New insider activity at Healthcare Realty Trust ( ($HR) ) has taken place on September 9, 2026. Healthcare Realty Trust’s Executive Vice President ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-major-healthcare-realty-trust-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-bold-move-with-major-healthcare-realty-trust-stock-sale-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XLV","BK4588","XBI","BK4581","HCSG","LU0128526141.USD","LU0029874061.USD","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559343","title":"Ramsay Health Care (RMSYF) Gets a Hold from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559343","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559343?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:05","pubTimestamp":1789002342,"startTime":"0","endTime":"0","summary":"In a report released today, Laura Sutcliffe from Citi maintained a Hold rating on Ramsay Health Care, with a price target of A$49.00. Sutcliffe cov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-hold-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","BK4185","BK4588","RMSYF","BK4585","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559315","title":"Citi Remains a Hold on Sonic Healthcare Limited (SHL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559315","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559315?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:05","pubTimestamp":1789002338,"startTime":"0","endTime":"0","summary":"Citi analyst Laura Sutcliffe maintained a Hold rating on Sonic Healthcare Limited today and set a price target of A$22.00. According to TipRanks, S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-hold-on-sonic-healthcare-limited-shl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-hold-on-sonic-healthcare-limited-shl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4585","BK4588","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666556378","title":"EBOS Group Limited (EBO) Gets a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666556378","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666556378?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:35","pubTimestamp":1789000522,"startTime":"0","endTime":"0","summary":"Citi analyst Laura Sutcliffe maintained a Buy rating on EBOS Group Limited today and set a price target of A$22.50. Sutcliffe covers the Healthcare...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ebos-group-limited-ebo-gets-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ebos-group-limited-ebo-gets-a-buy-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XBI","XLV","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666555425","title":"Positive Report for Fisher & Paykel Healthcare Corporation Limited (FSPKF) from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666555425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666555425?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:05","pubTimestamp":1788998756,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited received a Buy rating and price target from Citi analyst Laura Sutcliffe today. According to TipRank...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-fisher-paykel-healthcare-corporation-limited-fspkf-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-fisher-paykel-healthcare-corporation-limited-fspkf-from-citi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FSPKF","BK8004","BK4581","LABU","FPH.NZ","BK4082","XLV","XBI","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666558859","title":"Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558859?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:07","pubTimestamp":1788988020,"startTime":"0","endTime":"0","summary":"Health-care companies fell, but not by as much as the broad market, as traders rotated into sectors less sensitive to inflation and fuel costs.Tyra Biosciences fell sharply after the performance of a bladder-cancer drug candidate in a mid-stage clinical trial disappointed investors.Johnson & Johnson, which is also developing a bladder-cancer treatment, fell slightly.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","JNJ","BK4588","BK4581","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666304145","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666304145","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666304145?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:50","pubTimestamp":1788987000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1107 ET - Recent clinical-trial setbacks mean Novartis needs to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XBI","BK4588","LABU","XLV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666766537","title":"Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666766537","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666766537?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984060,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Sept.  09, 2026  -- Oruka Therapeutics, Inc.  , a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis and hidradenitis suppurativa, today announced its attendance at the 2026 Morgan Stanley Global Healthcare Conference, taking place in New York, NY from September 14-16, 2026.About Oruka TherapeuticsOruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from inflammatory diseases like plaque psoriasis and hidradenitis suppurativa the greatest possible freedom from their condition by achieving high rates of disease clearance with dosing as infrequently as once or twice a year. For more information, visit www.orukatx.com and follow Oruka on LinkedIn. Investor Contact:Alan Lada-606-7911alan.lada@orukatx.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3359049/0/en/oruka-therapeutics-to-attend-the-2026-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","BK4581","LU0795875086.SGD","LU1548497426.USD","LU0006306889.USD","LU0795875169.SGD","XLV","LU0971096721.USD","LU1064131342.USD","LU2028103732.USD","KBWB","BK4137","LENZ","LU0557290698.USD","BK4504","LU1162221912.USD","LU2347655156.SGD","IE00B3S45H60.SGD","LU0528227936.USD","LU1732799900.SGD","IE00BKVL7J92.USD","LU1720051017.SGD","BK4539","LU0234570918.USD","LU1668664300.SGD","LU0128526141.USD","LU2487616109.SGD","XBI","LU2089284900.SGD","LABU","LU0106261372.USD","LU0390134368.USD","LU0882574139.USD","LU2271345857.HKD","IE00BZ1G4Q59.USD","LU0912757837.SGD","BK4534","LU1791710582.SGD","BK4007","BK4139","LU1244550577.SGD","BK4516","LU2089283258.USD","BK4588","LU1989772840.SGD","LU0158827781.USD","LU0320765646.SGD","IAI","LU0098860793.USD","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537973","title":"COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537973","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537973?lang=en_us&edition=fundamental","pubTime":"2026-09-10 03:55","pubTimestamp":1788983722,"startTime":"0","endTime":"0","summary":"COMPASS Pathways, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Francois Brisebois from LifeSci Capital reit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/compass-pathways-strong-phase-3-trd-data-differentiated-positioning-support-unchanged-24-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/compass-pathways-strong-phase-3-trd-data-differentiated-positioning-support-unchanged-24-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","LABU","XLV","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666858537","title":"Bayer Gets FDA Accelerated Approval for Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666858537","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666858537?lang=en_us&edition=fundamental","pubTime":"2026-09-10 02:55","pubTimestamp":1788980100,"startTime":"0","endTime":"0","summary":"Bayer received accelerated approval from the Food and Drug Administration for its treatment of non-small cell lung cancer.The FDA approved sevabertinib as a first-line treatment for patients with adva","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LABU","BAYRY","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":5,"totalSize":411,"code":"91000000","status":"200"}]}}